Moderate riskFDA DrugClass II

AvKARE Rosuvastatin 10 mg tablets recalled for dissolution defect

AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.

From the FDA notice · Read the official notice ↗ · All AvKARE recalls

What to do

  1. Check if you have this medication: NDC 50268-709-15, Lot #49124, expiration date 12/31/2026
  2. Stop taking the affected tablets
  3. Contact your pharmacy or doctor for a replacement prescription
  4. Do not flush or throw away the medication; ask your pharmacy how to safely return or dispose of it

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
7,991 5x10 cartons
Illnesses reported
None reported
Manufactured in
615 N 1st St, Pulaski, TN, United States
Classification
Class II
Recall number
D-0292-2026

In the FDA's words

Description
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 Out of specification for dissolution. Lot #49124, Exp Date 12/31/2026 Distribution: Nationwide in the USA Affected quantity: 7,991 5x10 cartons
Hazard
Out of specification for dissolution.

More from AvKARE

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug